Group Business

The Group’s subsidiary, Hong Kong Cyclotron Laboratories Limited  (“HKCL”) was established in 2006. HKCL is a radio-pharmaceutical manufacturer that specializes in Positron Emission Tomography (“PET”) drugs such as Fluorodeoxyglucose (“FDG”). HKCL is an exclusive supplier of FDG to the Hong Kong SAR Government and major hospitals in Hong Kong, as well as one of the largest local PET drugs manufacturers providing PET drugs to hospitals, clinics, and imaging centres.